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Exonuclease 1 (EXO1) is one of several
nucleic acid-trimming enzymes required for
the repair of double strand breaks that con-
stitute the most toxic form of DNA damage.
By resecting DNA ends, this processive 50 to
30 exonuclease helps to produce recombi-
nogenic 30 overhangs, which are than cap-
tured by the homologous recombination
machinery to repair double strand breaks,
i.e., to reestablish an intact DNA double
helix.1 This mechanism raises the question
of how EXO1 is prevented from carrying
out excessive DNA digestions at strand
breaks, possibly generating even more
deleterious intermediates responsible for
chromosomal aberrations. Clearly, further
research is needed to understand the regu-
lation of EXO1 in the maintenance of
genome stability but, in the current issue of
Cell Cycle, Bologna et al.2 provide important
new insights into this challenging problem.
They report that, in conjunction, 2 related
peptide modiﬁers control the level and
enzymatic activity of EXO1 in human cells.
A ﬁrst hint for this newly discovered regula-
tory circuit came from the ﬁnding that
EXO1 undergoes ubiquitin-dependent pro-
teasomal degradation in response to agents
like hydroxyurea, aphidicolin or camptothe-
cin that cause replication stress by stalling
DNA replication forks. Interestingly, the
authors discovered that, in such genome-
threatening situations like replication stress,
both the ubiquitination of EXO1 and its
degradation are triggered by a preceding
conjugation with SUMO (for Small Ubiqui-
tin-like MOdiﬁer).
The SUMO cascade is an intensively stud-
ied protein modiﬁcation system with key roles
in diverse cellular processes. Like for posttran-
scriptional ubiquitination, the toolbox for pro-
tein sumoylation comprises a hierarchy of E1,
E2 and E3 enzymes. The SUMO moiety is acti-
vated in an ATP-dependent manner by the E1
activating enzyme and then transferred to an
E2 conjugating enzyme. This E2 conjugates
SUMO to target lysine residues either by direct
substrate recognition or with the assistance of
E3 ligases acting as substrate adapters. Recent
proteomic screens revealed a high prevalence
of SUMO substrates in DNA-metabolic path-
ways.3,4 By demonstrating sumoylation of
EXO1, Bologna and colleagues extend this
list of sumoylated DNA-resecting enzymes
(already including other nucleases like Rad1,
FEN1, Sae2/CtIP and the Mre11 complex) by
one additional entry and conﬁrm the para-
digm of SUMO-dependent processing of DNA
double strand breaks. In fact, the E2 and E3
enzymes (UBC9 and PIAS1, respectively)
involved in EXO1 sumoylation had been
shown previously to co-localize with sites of
DNA double strand break repair.5,6 The ﬁnding
that EXO1 is de-sumoylated by the SENP6 pro-
tease completes this regulatory circuit.
Figure 1. Dual control of EXO1 activity by conjugation with SUMO (S) and ubiquitin (U) reported by
Bologna et al.2 Constitutively sumoylated EXO1 is recruited to stalled replication forks induced by
treatment with hydroxyurea (HU; a ribonucleotide reductase inhibitor), aphidicolin (a DNA polymer-
ase inhibitor) or camptothecin (a topoisomerase-1 inhibitor). Upon substrate engagement and
resection, EXO1 is ubiquitinated and delivered to proteasomal destruction.
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To address the biological relevance of
EXO1 sumoylation, Bologna and colleagues
identiﬁed the lysine acceptor sites and gen-
erated an EXO1 triple mutant that is catalyt-
ically active, but refractory to sumoylation.
Since a central arena for SUMO actions
relates to pathways promoting genome sta-
bility, the authors next tested the impact of
EXO1 overexpression on chromosomal aber-
rations in camptothecin-treated cells. Over-
expression of wild-type EXO1 increases the
prevalence of chromosomal breaks, presum-
ably due to a disproportionate DNA-resect-
ing activity. However, this negative effect of
EXO1 on genome stability is attenuated
when, instead of the wild-type protein, the
SUMO-refractory triple mutant was overex-
pressed at the same protein level and
under the same conditions. Evidently, inter-
ference with sumoylation protects cells
experiencing replication stress from the del-
eterious consequences of an excess level of
EXO1
Based on these ﬁndings, Bologna and col-
leagues.2 proposed a model of how the conju-
gation of EXO1 with peptide modiﬁers is
linked to its function in handling replication
stress (Fig. 1). Their scheme involves recruit-
ment of constitutively sumoylated EXO1 to
DNA ends at stalled replication forks. SUMO
stimulates the catalytic activity of EXO1 during
DNA resection in the context of stalled replica-
tion forks and, upon full substrate engage-
ment, induces its ubiquitination. Thus, this
combination of constitutive sumoylation and
on-site ubiquitination ensures ﬁt-to-purpose
resection but prevents excessive digestion of
free DNA ends by EXO1. A challenge for the
future will be to understand how SUMO is
able to ﬁne-tune the enzymatic activity of
EXO1 independently of ubiquitin-dependent
degradation. In general terms, SUMO can
have effects either as a molecular “glue” or as
an “anti-glue” in modulating protein-protein
or protein-DNA interactions.7 Thus, one test-
able possibility is that SUMO moieties mediate
the association of EXO1 to binding partners
displaying SUMO-interacting motifs in struc-
tures assembled at stalled replication forks.
Another possibility is that SUMO residues
might facilitate the displacement of DNA-
binding proteins that sterically hinder accessi-
bility and DNA resection by EXO1.
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